AA
PROK icon

ALPS Advisors’s ProKidney PROK Stock Holding History

ALPS Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95,182
Closed -$83.4K – 1054
2025
Q1 		$83.4K Sell
95,182
-8,295
-8% -$11.5K ﹤0.01% 983
2024
Q4 		$175K Buy
103,477
+6,081
+6% +$11K ﹤0.01% 974
2024
Q3 		$187K Buy
97,396
+47,548
+95% +$108K ﹤0.01% 980
2024
Q2 		$123K Buy
+49,848
New +$134K ﹤0.01% 961
2023
Q4 		– Sell
-173,628
Closed -$795K – 1004
2023
Q3 		$795K Buy
173,628
+866
+0.5% +$8.29K 0.01% 520
2023
Q2 		$1.93M Buy
+172,762
New +$1.84M 0.02% 314

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ALPS Advisors's PROK Position: Q2 2025 in Review

ALPS Advisors sold out of ProKidney (PROK) in Q2 2025, closing a stake of 95,182 shares — an estimated $83.4K sold.

ALPS Advisors first reported a position in PROK in Q2 2023 and held it in 6 quarters. The position peaked at $1.93M in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • ALPS Advisors reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • ALPS Advisors sold 95,182 ProKidney shares in Q2 2025, an estimated $83.4K.
  • ALPS Advisors first reported a position in ProKidney in Q2 2023 and held it in 6 quarters.
  • ALPS Advisors's ProKidney position peaked at $1.93M in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on ALPS Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.